ClinicalTrials.gg
Not yet recruitingNCT07376408Updated Nov 5, 2026

Spousal Support and Sexual Quality of Life in Postmenopausal Women

An observational study in Postmenopausal, Support and Sexuality, sponsored by Istanbul University - Cerrahpasa. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Istanbul University - Cerrahpasa · Observational

Updated Nov 5, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
84
Sex
Female
01

Study summary

Menopause is a natural transition period in women's lives characterized by concurrent hormonal, psychological, and relational changes. During the postmenopausal period, hormonal alterations are not limited to physical symptoms but also have significant effects on psychological well-being, interpersonal relationships, and particularly sexual quality of life. Common concerns during this period include decreased sexual desire, vaginal dryness, pelvic discomfort, and reduced sexual satisfaction, all of which may negatively affect overall quality of life. Sexual quality of life is influenced not only by biological factors but also by psychological and relational dimensions.

The quality of partner relationships and perceived partner support play an important role in women's adaptation to sexual changes during the postmenopausal period. However, partner support during menopause is often reported to be insufficient, which may adversely affect sexual well-being. Despite this, evidence examining the relationship between perceived partner support and sexual quality of life in postmenopausal women remains limited.

The aim of this study is to examine the effect of perceived partner support on sexual quality of life in postmenopausal women. Through this investigation, the explanatory role of partner support in postmenopausal sexual well-being is aimed.

02

Conditions studied

  • Postmenopausal
  • Support
  • Sexuality

Browse trials for

Keywords

  • Postmenopausal
  • Sexuality
  • Quality of Life
  • Support
03

In context

Sexuality

130 studies on the registry are indexed under Sexuality; 26 are open to participants now.

This study's planned enrollment of 84 is below the median of 100 across 47 observational studies indexed under Sexuality.

Browse Sexuality studies →

Lead sponsor

Istanbul University - Cerrahpasa is the lead sponsor of 699 studies on the registry; 213 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of postmenopausal women registered at Family Health Centers in Istanbul, Türkiye. Eligible participants are women who are in the postmenopausal period, defined as having experienced at least 12 consecutive months of amenorrhea, who have a partner, and who voluntarily agree to participate in the study. Data will be collected using self-reported questionnaires, and no intervention will be applied.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • status, defined as at least 12 consecutive months of amenorrhea
  • Having a partner
  • Voluntary agreement to participate in the study and provision of written

Exclusion criteria

Exclusion Criteria:

  • Visual, cognitive, or other impairments that prevent completion of the study questionnaires
  • History of major gynecological surgery within the past 6 months
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
84 participants (estimated)
Patient registry
No

Groups and cohorts

  • Postmenopausal Women

    Postmenopausal women with a partner, registered at Family Health Centers in Istanbul, who participate in this observational study to assess perceived spousal support and sexual quality of life. No intervention is applied.

    Other: No Intervention

Interventions

  • OtherNo Intervention

    This is an observational study. No intervention, treatment, or behavioral modification is applied. Data are collected using self-reported questionnaires only.

06

What researchers measure

Primary outcomes

  1. Introduction Information Forum

    This form was developed by the researchers based on the relevant literature and consists of 36 items assessing participants' sociodemographic and clinical characteristics, including age, educational level, employment status, duration of marriage, duration of menopause, and presence of chronic disease.

    Time frame: At enrollment

  2. The Sexual Quality of Life-Female Questionnaire

    The Sexual Quality of Life-Female Questionnaire (SQoL-F) was developed by Symonds et al. (2005) to assess women's perceived sexual quality of life. The Turkish validity and reliability study was conducted by Tugut and Golbasi (2010). The scale consists of 18 items, each rated on a 6-point Likert scale (1 = Completely agree, 6 = Completely disagree). The raw total score ranges from 18 to 108. Items 1, 5, 9, 13, and 18 are reverse scored prior to calculating the total score. The raw total score is transformed to a 0-100 scale using the following formula: (raw score - 18) × 100 / 90. Higher scores indicate better sexual quality of life, whereas lower scores indicate poorer sexual quality of life. The Cronbach's alpha coefficient of the Turkish version is reported as 0.83.

    Time frame: At enrollment

  3. The Menopause Spousal Support Scale

    The Menopause Spousal Support Scale was developed to assess perceived spousal support among women during menopause. The Turkish validity and reliability study was conducted by Küçükkelepçe et al. (2024). The scale consists of 17 items and includes four subscales: emotional support, instrumental support, esteem support, and sexual intimacy support. Items are rated on a 10-point Likert scale ranging from 1 (never) to 10 (almost always). The total score ranges from 17 to 170. Higher scores indicate greater perceived spousal support, whereas lower scores indicate lower perceived spousal support. The Cronbach's alpha coefficient of the Turkish version is 0.96.

    Time frame: At enrollment

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Start date
Feb 2026→Sep 2027
Nov 5, 2026
Primary completion
Feb 2027→Dec 2027
Nov 5, 2026
Study completion
Feb 2027→Dec 2027
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Start date Feb 2026→Sep 2027
    Primary completion Feb 2027→Dec 2027
    Study completion Feb 2027→Dec 2027

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07376408
Responsible party
Eslem Altıntaş (MSc, Acibadem University) — Principal investigator
First posted
Jan 29, 2026
Start date
Sep 2027 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Nov 5, 2026

Study contacts

Eslem Altıntaş, MSc
Contact
eslem.altintas@acibadem.edu.tr
+90 541 610 54 12
Merve Coşkun, Ph.D.
principal investigator · Acibadem University
Nevin Şahin, Prof. Dr.
principal investigator · Istanbul University-Cerrahpaşa, Institute of Graduate Studies, PhD Program

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion